Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Reboxetine MeSH Descriptor Data 2026


MeSH Heading
Reboxetine
Tree Number(s)
D03.383.533.640.682
Unique ID
D000077593
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077593
Scope Note
A morpholine derivative that is a selective and potent noradrenaline reuptake inhibitor; it is used in the treatment of DEPRESSIVE DISORDER.
Entry Term(s)
2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate
Reboxetine Mesylate
Vestra
Pharm Action
Antidepressive Agents
Adrenergic Uptake Inhibitors
Registry Numbers
947S0YZ36I
L94J81YNNY
0
Related Numbers
98769-81-4
L94J81YNNY
CAS Type 1 Name
Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-
Public MeSH Note
2019; REBOXETINE was indexed under MORPHOLINES 1992-2018
History Note
2019 (1992)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Reboxetine Preferred
Reboxetine Mesylate Narrower
Vestra Narrower
page delivered in 0.119s